Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,210 | 0.0% | 44,472 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 1,592 | 0.0% | 33,318 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 1,192 | 0.0% | 37,810 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 1,715 | 0.0% | 52,361 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 1,893 | 0.0% | 52,361 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 1,633 | 0.0% | 52,361 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 1,489 | 0.0% | 55,661 | 6/30/2024 |
| 2024 Q1 | 10/8/2025 | 1,898 | 0.0% | 55,632 | 3/31/2024 |
| 2023 Q4 | 10/8/2025 | 1,492 | 0.0% | 51,547 | 12/31/2023 |
| 2023 Q3 | 10/8/2025 | 1,681 | 0.0% | 60,983 | 9/30/2023 |
| 2023 Q2 | 10/8/2025 | 1,829 | 0.0% | 60,860 | 6/30/2023 |
| 2023 Q1 | 10/8/2025 | 4,103 | 0.0% | 113,249 | 3/31/2023 |
| 2022 Q4 | 10/8/2025 | 7,152 | 0.0% | 200,492 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 6,619 | 0.0% | 195,553 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 6,985 | 0.0% | 241,519 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 3,202 | 0.0% | 99,066 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 3,016 | 0.0% | 103,444 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 1,937 | 0.0% | 72,622 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 2,256 | 0.0% | 73,261 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 1,988 | 0.0% | 75,948 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 1,911 | 0.0% | 75,948 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 1,583 | 0.0% | 75,948 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 1,637 | 0.0% | 68,914 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 1,171 | 0.0% | 65,064 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 1,051 | 0.0% | 44,300 | 12/31/2019 |